Effect of atorvastatin on left ventricular, diastolic function and ability of coenzyme Q10 to reverse that dysfunction

被引：73

作者：

Silver, MA

Langsjoen, PH

Szabo, S

Patil, H

Zelinger, A

机构：

[1] Advocate Christ Med Ctr, Cardiol Sect, Dept Med, Oak Lawn, IL 60453 USA

[2] Univ Illinois, Christ Cardiovasc Dis Fellowship Program, Oak Lawn, IL USA

[3] E Texas Med Ctr, Tyler, TX USA

[4] Trinity Mother Francis Hlth Syst, Tyler, TX USA

[5] Heart Failure Inst, Advocate Christ Med Ctr, Dept Med, Oak Lawn, IL 60453 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 10期

关键词：

D O I：

10.1016/j.amjcard.2004.07.121

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This study evaluated left ventricular diastolic function with Doppler echocardiography before and after statin therapy. Statin therapy worsened diastolic parameters in most patients; coenzyme Q(10) supplementation in patients with worsening diastolic function with statin therapy improved parameters of diastolic function. (C) 2004 by Excerpta Medica, Inc.

引用

收藏

页码：1306 / 1310

页数：5

相关论文

共 11 条

[1] Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study [J].

Athyros, VG ;

Papageorgiou, AA ;

Mercouris, BR ;

Athyrou, VV ;

Symeonidis, AN ;

Basayannis, EO ;

Demitriadis, DS ;

Kontopoulos, AG .

CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) :220-228

[2] EXOGENOUS COQ(10) PRESERVES PLASMA UBIQUINONE LEVELS IN PATIENTS TREATED WITH 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS [J].

BARGOSSI, AM ;

BATTINO, M ;

GADDI, A ;

FIORELLA, PL ;

GROSSI, G ;

BAROZZI, G ;

DIGIULIO, R ;

DESCOVICH, G ;

SASSI, S ;

GENOVA, ML ;

LENAZ, G .

INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1994, 24 (03) :171-176

[3] Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease [J].

Bountioukos, M ;

Rizzello, V ;

Krenning, BJ ;

Bax, JJ ;

Kertai, MD ;

Vourvouri, EC ;

Schinkel, AFL ;

Biagini, E ;

Boersma, E ;

Roelandt, JRTC ;

Poldermans, D .

AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (05) :613-616

[4] EVIDENCE OF PLASMA COQ10-LOWERING EFFECT BY HMG-COA REDUCTASE INHIBITORS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].

GHIRLANDA, G ;

ORADEI, A ;

MANTO, A ;

LIPPA, S ;

UCCIOLI, L ;

CAPUTO, S ;

GRECO, AV ;

LITTARRU, GP .

JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (03) :226-229

[5] Statins and chronic heart failure: Do we need a large-scale outcome trial? [J].

Krum, H ;

McMurray, JJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (10) :1567-1573

[6]

LANGSJOEN PH, 1993, CLIN INVESTIGATOR, V71, pS140

[7] The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10.: A review of animal and human publications [J].

Langsjoen, PH ;

Langsjoen, AM .

BIOFACTORS, 2003, 18 (1-4) :101-111

[8]

Mortensen SA, 1997, MOL ASPECTS MED, V18, pS137

[9]

ODA T, 1994, MOL ASPECTS MED, V15, P149

[10] Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke [J].

Rundek, T ;

Naini, A ;

Sacco, R ;

Coates, K ;

DiMauro, S .

ARCHIVES OF NEUROLOGY, 2004, 61 (06) :889-892